Comparison of clinicopathological features of patients with hepatocellular carcinoma seropositive fora-fetoprotein alone and those seropositive for des-γ-carboxy prothrombin alone

Journal of Gastroenterology and Hepatology (Australia)

Volumn 16, Issue 11, 2001, Pages 1290-1296

  Okuda, Hiroaki ^a   Nakanishi, Toshimi ^a   Takatsu, Kazuko ^a   Saito, Akiko ^a   Hayashi, Naoaki ^a   Yamamoto, Masakazu ^a   Takasaki, Ken ^a   Nakano, Masayuki ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b National Mito Hospital   (Japan)

Author keywords

Clinicopathological features; Des carboxy prothrombin; Hepatocellular carcinoma; Seropositivity; fetoprotein

Indexed keywords

ALPHA FETOPROTEIN; DECARBOXYPROTHROMBIN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CANCER INCIDENCE; CELL DIFFERENTIATION; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TUMOR VOLUME;

EID: 0035698289     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2001.02610.x     Document Type: Article

References (34)

1. Primary liver cell carcinoma
2. A collaborative study for the evaluation of a serologic test for primary liver cancer
3. Radioimmunoassay of alpha-fetoprotein in hepatoma, other liver diseases and pregnancy
4. Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels
5. Des-γ-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma
6. Detection of vitamin K deficiency by use of an enzyme-linked immunosorbent assay for circulating abnormal prothrombin
7. Production of abnormal prothrombin (des-γ-carboxyprothrombin) by hepatocellular carcinoma: A clinical and experimental study
8. Plasma abnormal prothrombin (des-γ-carboxy prothrombin) as a marker of hepatocellular carcinoma
9. A new method to assay des-γ-carboxy prothrombin. Results obtained in 75 cases of hepatocellular carcinoma
10. A comparison between des-g-carboxy prothrombin and α-fetoprotein as markers of hepatocellular carcinoma in southern African Blacks
11. Changes of plasma des-γ-carboxy prothrombin levels in patients with hepatocellular carcinoma in response to vitamin K
12. Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions
13. Monitoring of lectin-reactive α-fetoprotein in patients with hepatocellular carcinoma treated using transcatheter arterial embolization
14. Measurement of serum levels of des-γ-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity
15. Serum levels of des-γ-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma
16. Usefulness of ED036 kit for measuring serum PIVKA-II levels in small hepatocellular carcinoma
17. The usefulness of determining des-γ-carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma
18. Serum des-gamma-carboxy prothrombin levels determined by a new generation of sensitive immunoassays in patients with small-sized hepatocellular carcinoma
19. Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma-Comparison with alpha-fetoprotein
20. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma
21. Vitamin K-dependent proteins and hepatocellular carcinoma
22. Levels of vitamin K, immunoreactive prothrombin, des-γ-carboxy prothrombin and γ-glutamyl carboxylase activity in hepatocellular carcinoma tissue
23. Clinical usefulness of des-γ-carboxy prothrombin assay in early diagnosis of hepatocellular carcinoma
24. Relationship between serum alpha-fetoprotein, cirrhosis, and survival in hepatocellular carcinoma
25. Significance of alpha-fetoprotein levels for detection of early recurrence of hepatocellular carcinoma after hepatic resection
26. Des-γ-carboxy prothrombin and α-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinoma
27. Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-γ-carboxy prothrombin and low serum α-fetoprotein
28. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment
29. Antibody-affinity blotting, a sensitive technique for the detection of α-fetoprotein separated by lectin-affinity electrophoresis in agarose gels
30. Des-gamma-carboxy prothrombin and proliferative activity of hepatocellular carcinoma
31. Relationship between pathologic prognostic factors and abnormal levels of des-γ-carboxy prothrombin and α-fetoprotein in hepatocellular carcinoma
32. Double signal hypothesis for thrombin initiation of cell proliferation
33. Role of thrombin in the proliferative response of T-47D mammary tumor cells